ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-inflammatory Medicine for Pets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28S12663
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Anti inflammatory Medicine for Pets Market Research Report 2023
BUY CHAPTERS

Global Anti-inflammatory Medicine for Pets Market Research Report 2025

Code: QYRE-Auto-28S12663
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zoetis Inc
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan Chopperlvya
CAHIC

Anti-inflammatory Medicine for Pets Market Size

The global market for Anti-inflammatory Medicine for Pets was valued at US$ 1281 million in the year 2024 and is projected to reach a revised size of US$ 1915 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Anti-inflammatory Medicine for Pets Market

Anti-inflammatory Medicine for Pets Market

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Medicine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Medicine for Pets.
The Anti-inflammatory Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Medicine for Pets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Medicine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-inflammatory Medicine for Pets Market Report

Report Metric Details
Report Name Anti-inflammatory Medicine for Pets Market
Accounted market size in year US$ 1281 million
Forecasted market size in 2031 US$ 1915 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Powder
  • Liquid
Segment by Application
  • Cat
  • Dog
  • Reptile
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-inflammatory Medicine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anti-inflammatory Medicine for Pets Market growing?

Ans: The Anti-inflammatory Medicine for Pets Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Anti-inflammatory Medicine for Pets Market size in 2031?

Ans: The Anti-inflammatory Medicine for Pets Market size in 2031 will be US$ 1915 million.

What is the Anti-inflammatory Medicine for Pets Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Anti-inflammatory Medicine for Pets Market report?

Ans: The main players in the Anti-inflammatory Medicine for Pets Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC

What are the Application segmentation covered in the Anti-inflammatory Medicine for Pets Market report?

Ans: The Applications covered in the Anti-inflammatory Medicine for Pets Market report are Cat, Dog, Reptile, Other

What are the Type segmentation covered in the Anti-inflammatory Medicine for Pets Market report?

Ans: The Types covered in the Anti-inflammatory Medicine for Pets Market report are Powder, Liquid

Recommended Reports

Veterinary Pharmaceuticals

Animal Health Solutions

Pet Nutrition & Wellness

1 Anti-inflammatory Medicine for Pets Market Overview
1.1 Product Definition
1.2 Anti-inflammatory Medicine for Pets by Type
1.2.1 Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Anti-inflammatory Medicine for Pets by Application
1.3.1 Global Anti-inflammatory Medicine for Pets Market Value by Application (2024 VS 2031)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Anti-inflammatory Medicine for Pets Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Medicine for Pets Revenue 2020-2031
1.4.2 Global Anti-inflammatory Medicine for Pets Sales 2020-2031
1.4.3 Global Anti-inflammatory Medicine for Pets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-inflammatory Medicine for Pets Market Competition by Manufacturers
2.1 Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-inflammatory Medicine for Pets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-inflammatory Medicine for Pets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Product Type & Application
2.7 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Date of Enter into This Industry
2.8 Global Anti-inflammatory Medicine for Pets Market Competitive Situation and Trends
2.8.1 Global Anti-inflammatory Medicine for Pets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-inflammatory Medicine for Pets Players Market Share by Revenue
2.8.3 Global Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-inflammatory Medicine for Pets Market Scenario by Region
3.1 Global Anti-inflammatory Medicine for Pets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-inflammatory Medicine for Pets Sales by Region: 2020-2031
3.2.1 Global Anti-inflammatory Medicine for Pets Sales by Region: 2020-2025
3.2.2 Global Anti-inflammatory Medicine for Pets Sales by Region: 2026-2031
3.3 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2020-2031
3.3.1 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2020-2025
3.3.2 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2026-2031
3.4 North America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory Medicine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-inflammatory Medicine for Pets Sales by Country (2020-2031)
3.4.3 North America Anti-inflammatory Medicine for Pets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory Medicine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-inflammatory Medicine for Pets Sales by Country (2020-2031)
3.5.3 Europe Anti-inflammatory Medicine for Pets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory Medicine for Pets Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-inflammatory Medicine for Pets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-inflammatory Medicine for Pets Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory Medicine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-inflammatory Medicine for Pets Sales by Country (2020-2031)
3.7.3 Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory Medicine for Pets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2020-2031)
4.1.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2020-2025)
4.1.2 Global Anti-inflammatory Medicine for Pets Sales by Type (2026-2031)
4.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2020-2031)
4.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2020-2031)
4.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Type (2020-2025)
4.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2026-2031)
4.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2020-2031)
4.3 Global Anti-inflammatory Medicine for Pets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2020-2031)
5.1.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2020-2025)
5.1.2 Global Anti-inflammatory Medicine for Pets Sales by Application (2026-2031)
5.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2020-2031)
5.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2020-2031)
5.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Application (2020-2025)
5.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2026-2031)
5.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2020-2031)
5.3 Global Anti-inflammatory Medicine for Pets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Anti-inflammatory Medicine for Pets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Anti-inflammatory Medicine for Pets Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Virbac Anti-inflammatory Medicine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Company Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Anti-inflammatory Medicine for Pets Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Company Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Company Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Company Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Norbrook Anti-inflammatory Medicine for Pets Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Company Information
6.11.2 Jindun Description and Business Overview
6.11.3 Jindun Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jindun Anti-inflammatory Medicine for Pets Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Company Information
6.12.2 Wuhan chopperlvya Description and Business Overview
6.12.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Company Information
6.13.2 CAHIC Description and Business Overview
6.13.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CAHIC Anti-inflammatory Medicine for Pets Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory Medicine for Pets Industry Chain Analysis
7.2 Anti-inflammatory Medicine for Pets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory Medicine for Pets Production Mode & Process Analysis
7.4 Anti-inflammatory Medicine for Pets Sales and Marketing
7.4.1 Anti-inflammatory Medicine for Pets Sales Channels
7.4.2 Anti-inflammatory Medicine for Pets Distributors
7.5 Anti-inflammatory Medicine for Pets Customer Analysis
8 Anti-inflammatory Medicine for Pets Market Dynamics
8.1 Anti-inflammatory Medicine for Pets Industry Trends
8.2 Anti-inflammatory Medicine for Pets Market Drivers
8.3 Anti-inflammatory Medicine for Pets Market Challenges
8.4 Anti-inflammatory Medicine for Pets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zoetis Inc
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan Chopperlvya
CAHIC
List of Tables
 Table 1. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-inflammatory Medicine for Pets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-inflammatory Medicine for Pets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-inflammatory Medicine for Pets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-inflammatory Medicine for Pets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-inflammatory Medicine for Pets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-inflammatory Medicine for Pets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-inflammatory Medicine for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Medicine for Pets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-inflammatory Medicine for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-inflammatory Medicine for Pets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-inflammatory Medicine for Pets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-inflammatory Medicine for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-inflammatory Medicine for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-inflammatory Medicine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-inflammatory Medicine for Pets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti-inflammatory Medicine for Pets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti-inflammatory Medicine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-inflammatory Medicine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-inflammatory Medicine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-inflammatory Medicine for Pets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti-inflammatory Medicine for Pets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti-inflammatory Medicine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-inflammatory Medicine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-inflammatory Medicine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-inflammatory Medicine for Pets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti-inflammatory Medicine for Pets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Anti-inflammatory Medicine for Pets Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Anti-inflammatory Medicine for Pets Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Elanco Company Information
 Table 86. Elanco Description and Business Overview
 Table 87. Elanco Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Elanco Anti-inflammatory Medicine for Pets Product
 Table 89. Elanco Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Virbac Anti-inflammatory Medicine for Pets Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Dechra Veterinary Products Company Information
 Table 96. Dechra Veterinary Products Description and Business Overview
 Table 97. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product
 Table 99. Dechra Veterinary Products Recent Developments/Updates
 Table 100. Ceva Company Information
 Table 101. Ceva Description and Business Overview
 Table 102. Ceva Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ceva Anti-inflammatory Medicine for Pets Product
 Table 104. Ceva Recent Developments/Updates
 Table 105. Vetoquinol Company Information
 Table 106. Vetoquinol Description and Business Overview
 Table 107. Vetoquinol Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Vetoquinol Anti-inflammatory Medicine for Pets Product
 Table 109. Vetoquinol Recent Developments/Updates
 Table 110. Ouro Fino Saude Company Information
 Table 111. Ouro Fino Saude Description and Business Overview
 Table 112. Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ouro Fino Saude Anti-inflammatory Medicine for Pets Product
 Table 114. Ouro Fino Saude Recent Developments/Updates
 Table 115. Norbrook Company Information
 Table 116. Norbrook Description and Business Overview
 Table 117. Norbrook Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Norbrook Anti-inflammatory Medicine for Pets Product
 Table 119. Norbrook Recent Developments/Updates
 Table 120. Jindun Company Information
 Table 121. Jindun Description and Business Overview
 Table 122. Jindun Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jindun Anti-inflammatory Medicine for Pets Product
 Table 124. Jindun Recent Developments/Updates
 Table 125. Wuhan chopperlvya Company Information
 Table 126. Wuhan chopperlvya Description and Business Overview
 Table 127. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product
 Table 129. Wuhan chopperlvya Recent Developments/Updates
 Table 130. CAHIC Company Information
 Table 131. CAHIC Description and Business Overview
 Table 132. CAHIC Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. CAHIC Anti-inflammatory Medicine for Pets Product
 Table 134. CAHIC Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Anti-inflammatory Medicine for Pets Distributors List
 Table 138. Anti-inflammatory Medicine for Pets Customers List
 Table 139. Anti-inflammatory Medicine for Pets Market Trends
 Table 140. Anti-inflammatory Medicine for Pets Market Drivers
 Table 141. Anti-inflammatory Medicine for Pets Market Challenges
 Table 142. Anti-inflammatory Medicine for Pets Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-inflammatory Medicine for Pets
 Figure 2. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-inflammatory Medicine for Pets Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Anti-inflammatory Medicine for Pets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-inflammatory Medicine for Pets Market Share by Application: 2024 & 2031
 Figure 8. Cat
 Figure 9. Dog
 Figure 10. Reptile
 Figure 11. Other
 Figure 12. Global Anti-inflammatory Medicine for Pets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Anti-inflammatory Medicine for Pets Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Anti-inflammatory Medicine for Pets Sales (2020-2031) & (K Units)
 Figure 15. Global Anti-inflammatory Medicine for Pets Average Price (US$/Unit) & (2020-2031)
 Figure 16. Anti-inflammatory Medicine for Pets Report Years Considered
 Figure 17. Anti-inflammatory Medicine for Pets Sales Share by Manufacturers in 2024
 Figure 18. Global Anti-inflammatory Medicine for Pets Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Anti-inflammatory Medicine for Pets Players: Market Share by Revenue in Anti-inflammatory Medicine for Pets in 2024
 Figure 20. Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Anti-inflammatory Medicine for Pets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Anti-inflammatory Medicine for Pets Sales Market Share by Country (2020-2031)
 Figure 23. North America Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2020-2031)
 Figure 24. United States Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Anti-inflammatory Medicine for Pets Sales Market Share by Country (2020-2031)
 Figure 27. Europe Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Anti-inflammatory Medicine for Pets Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2020-2031)
 Figure 35. China Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Anti-inflammatory Medicine for Pets Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Anti-inflammatory Medicine for Pets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Anti-inflammatory Medicine for Pets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Anti-inflammatory Medicine for Pets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Anti-inflammatory Medicine for Pets by Type (2020-2031)
 Figure 55. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Anti-inflammatory Medicine for Pets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Anti-inflammatory Medicine for Pets by Application (2020-2031)
 Figure 58. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2020-2031)
 Figure 59. Anti-inflammatory Medicine for Pets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Preventive Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antimicrobials for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Insecticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Intestinal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Pharmaceuticals Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Small Companion Animal Drug Market Research Report 2024
Global Pet NSAIDs Market Research Report 2025
Global Pet Veterinary Drug Market Insights Forecast to 2030
Global Pet Antibiotic Market Research Report 2025
Global Pets Anti Infective Medicine Market Insights Forecast to 2030
Global Pets NSAIDs Market Research Report 2025
Animal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pet Drug and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Animal Anti Infective Medicine Market Insights Forecast to 2030
Dermatology Drugs for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pets External Medicine Market Insights Forecast to 2030
Global Veterinary Drugs for Companion Animals Market Research Report 2025
Global Over The Counter OTC Pet Medication Market Research Report 2024
Pet Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions